Cookie Control

We only use technically necessary cookies. By clicking on "OK" you have taken note of this. You can also find further information in our data protection declaration.

Skip to main content

Total Arthroplasty in Perfection

Welcome to the web site of PETER BREHM GmbH.

As a manufacturer of medical implants and prostheses, we work in a field that demands maximum reliability of products and thus maximum safety for patients. Therefore we feel it is very important to inform you comprehensively about our company and our various products for total knee and hip arthroplasty as well as spinal surgery.

Please contact us if you have any questions or require more detailed material. Naturally we are grateful for any suggestions you may have for improving our web site.

March 2nd, 2020

Attis Medical announced the succesful launch of the BPK-S integration knee system on 11 and 12th February in Campinas-SP, Brazil. PETER BREHM’s experts Dr. Olaf Stevens (sales director international) and Claus Windisch (head of product development) conducted the theoretical and practical training of the participants.

Read more in LinkedIn

News

December 2nd, 2019

The German PETER BREHM GmbH and the Swiss Mathys Ltd Bettlach have agreed on a long-term strategic sales cooperation. The contract was signed last week.

Open Media Release (PDF)

February 24th, 2020

The recent publication of a retrospective cohort study on the modular knee arthrodesis KAM-TITAN showed a survival rate of the implant of 85%, good functional results (Oxford Knee Score) with low postoperative pain (VAS) and a low reinfection rate in the follow-up period. Illustrations guide through the surgical technique.

Read more in LinkedIn

Events

2020
11
September
11.09.2020, Uhr
Meet #PETERBREHM in Dortmund.
Dortmund
2020
17
September
17.09.2020, Uhr
Meet #PETERBREHM at the DGOOC hip course in Berlin.
Berlin
2020
18
September
18.09.2020, Uhr
Meet #PETERBREHM at the masterclass knee.
Munich

Award-winning products

Our commitment

Our Partner

  • Facebook
  • Twitter
  • XING